KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $361.7 million.

  • Charles River Laboratories International's Depreciation & Amortization (CF) fell 3.44% to $85.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $427.1 million, marking a year-over-year increase of 25.57%. This contributed to the annual value of $361.7 million for FY2024, which is 15.16% up from last year.
  • Per Charles River Laboratories International's latest filing, its Depreciation & Amortization (CF) stood at $361.7 million for FY2024, which was up 15.16% from $314.1 million recorded in FY2023.
  • Charles River Laboratories International's Depreciation & Amortization (CF)'s 5-year high stood at $361.7 million during FY2024, with a 5-year trough of $234.9 million in FY2020.
  • Over the past 3 years, Charles River Laboratories International's median Depreciation & Amortization (CF) value was $314.1 million (recorded in 2023), while the average stood at $326.6 million.
  • Data for Charles River Laboratories International's Depreciation & Amortization (CF) shows a peak YoY increased of 18.59% (in 2020) over the last 5 years.
  • Charles River Laboratories International's Depreciation & Amortization (CF) (Yearly) stood at $234.9 million in 2020, then rose by 13.03% to $265.5 million in 2021, then grew by 14.43% to $303.9 million in 2022, then increased by 3.37% to $314.1 million in 2023, then increased by 15.16% to $361.7 million in 2024.